Anúncio
Anúncio

TECH

TECH logo

Bio-Techne Corp.

65.28
USD
Patrocinado
+2.25
+3.56%
06 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

65.28

0.00
0.00%

Relatórios de Lucros TECH

Rácio de surpresa positiva

TECH separação 24 de 39 últimas estimativas.

62%

Próximo Relatório

Data do Próximo Relatório
03 de fev. de 2026
Estimate for Q2 26 (Revenue/ EPS)
$295.99M
/
$0.44
Mudanças implicadas de Q1 26 (Revenue/ EPS)
+3.29%
/
+4.76%
Mudanças implicadas de Q2 25 (Revenue/ EPS)
+0.28%
/
+4.76%

Bio-Techne Corp. earnings per share and revenue

On 05 de nov. de 2025, TECH reported earnings of 0.42 USD per share (EPS) for Q1 26, missing the estimate of 0.42 USD, resulting in a -2.03% surprise. Revenue reached 286.56 milhão, compared to an expected 297.05 milhão, with a -3.53% difference. The market reacted with a -1.90% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 16 analistas forecast an EPS of 0.44 USD, with revenue projected to reach 295.99 milhão USD, implying an aumentar of 4.76% EPS, and aumentar of 3.29% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
For Q1 2026, Bio-Techne Corp. reported EPS of $0.42, missing estimates by -2.03%, and revenue of $286.56M, -3.53% below expectations.
The stock price moved down -1.9%, changed from $61.10 before the earnings release to $59.94 the day after.
The next earning report is scheduled for 03 de fev. de 2026.
Based on 16 analistas, Bio-Techne Corp. is expected to report EPS of $0.44 and revenue of $295.99M for Q2 2026.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio